23 May 2013
Keywords: gsk, plans, aids, vaccine, trials, later, highlights
Article | 23 February 2001
One of the highlights of GlaxoSmithKline's inaugural R&D presentation(see also Marketletter February 22) was the announcement that it would
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2001
22 February 2001
© 2013 thepharmaletter.com